Moreno, C., Aiello, A., Di Virgilio, R., Mazzotta, V. and Antinori, A. 2025. Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19. Global and Regional Health Technology Assessment. 11, 1 (Jul. 2025), 168–176. DOI:https://doi.org/10.33393/grhta.2024.3403.